Get started
Author

Paula Llabata

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
2021 · Octavio A. Romero, Andrea Vilarrubi, et al. · Nature Communications · 67
MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
2023 · Juan J. Alburquerque-Bejar, Pablo Navajas-Chocarro, et al. · Cell Reports Medicine · 46
PDF
Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma
2019 · Paula Llabata, Yoichiro Mitsuishi, et al. · Molecular Cancer Research · 43
Arabidopsis ILITHYIA protein is necessary for proper chloroplast biogenesis and root development independent of eIF2α phosphorylation
2018 · I. Faus, R. Niñoles, et al. · Journal of Plant Physiology · 20
PDF
Involvement of the eIF2α Kinase GCN2 in UV-B Responses
2019 · Paula Llabata, Julia Richter, et al. · Frontiers in Plant Science · 15
PDF
MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex
2021 · Paula Llabata, Manuel Torres-Diz, et al. · Proceedings of the National Academy of Sciences · 14
How the West(ern) was won: Solutions for immunoblotting large and small proteins
2023 · Paula Llabata, Pere Llinàs-Arias · Gene & Protein in Disease
MA17.05 DNA-Binding and Gene Expression Profiles in Max Deficient Small Cell Lung Cancer
2019 · P. Llabata, M. Torres-Diz, et al. · Journal of Thoracic Oncology
EP1.14-39 BRG1 Deficient Cells Are Sensitive to the Inhibition of Specific Lysine Demethylases (KDMs) in Lung Cancer
2019 · A. Vilarrubí Porta, J.J. Alburquerque Béjar, et al. · Journal of Thoracic Oncology
P3.02-086 MGA Suppresses the MYC Pathway in Lung Adenocarcinoma
2017 · P. Llabata, Y. Mitsuishi, et al. · Journal of Thoracic Oncology
Works count: 10
Citation count: 205
H-index: 6
I10-index: 6
Year
Topic
Type